Investors Rotating Out of Tech Are Making a Mistake. This AI Growth Stock's Revenue Just Hit a Record.

Broadcom reported record fiscal 2025 revenue of $63.9 billion, with AI chip sales up 65% to $20 billion and management expecting AI revenue to rise to $60 billion-$90 billion by fiscal 2027. Analysts project revenue and adjusted EBITDA CAGRs of 47% and 46% from fiscal 2025 to fiscal 2028, supporting the view that AI demand still has substantial runway. The article frames Broadcom as a bellwether for AI spending and suggests investors may be underestimating long-term growth in the tech sector.

Analysis

Broadcom’s signal is less about one stock and more about the persistence of AI capex beyond the initial GPU training phase. The second-order read is that hyperscalers are increasingly optimizing for inference economics and power efficiency, which shifts bargaining power toward custom silicon vendors and away from generalized compute vendors. That should support a broader re-rating of “pick-and-shovel” AI infrastructure names, but it also raises the bar for companies whose AI monetization depends on training-only demand.

The most important implication is competitive fragmentation inside AI hardware, not a clean winner-take-all outcome. If custom accelerators keep taking share, NVDA’s growth can remain strong while mix pressure increases in the outer years; meanwhile, META and GOOGL likely benefit from lower unit inference costs and better payback on model deployment. The supply-chain beneficiary set also broadens into advanced packaging, networking, and power-management vendors, because the real constraint shifts from model training demand to rack-level deployment efficiency.

The contrarian risk is that consensus may be extrapolating hyperscaler spend too far out on the curve. The next 2-3 quarters matter: if cloud capex flattens or inference workloads monetize slower than expected, the market can compress multiples quickly even if long-term AI demand remains intact. Broadcom looks sturdy, but at these levels the trade is more about duration risk than business risk; a miss on AI revenue ramp timing would likely hit sentiment harder than fundamentals.

For portfolio positioning, this argues for staying long AI infrastructure but being selective on valuation and product mix. The cleaner expression is to own the vendors most leveraged to inference economics and to hedge the names whose upside still depends on sustained training intensity. In other words, participate in the AI cycle, but don’t treat every trillion-dollar market cap as equally protected from a capex pause.

Key Decisions for Investors

• Maintain a core long AVGO into the next 1-2 quarters, but size it below a full momentum weight; use any 5-8% drawdown tied to capex fears as the entry window, since the risk/reward is still favorable if inference spend inflects as expected.
• Pair long AVGO vs short a basket of AI names more dependent on training demand or valuation expansion, such as NVDA on a relative basis if the market starts discounting custom-ASIC share gains; target a 3-6 month horizon and use a 10-15% relative stop.
• Add to GOOGL and META on weakness as indirect beneficiaries of lower inference costs; the trade works if custom silicon improves internal AI economics and supports faster product rollout over the next 2-4 quarters.
• Buy upside exposure to AI infrastructure through call spreads rather than outright stock in higher-beta suppliers; this captures the 6-12 month re-rating if hyperscaler capex remains resilient while limiting downside if guidance moderates.
• Watch for any sign of AI revenue ramp disappointment at AVGO as a sector tell; if growth guidance decelerates, rotate risk out of semi-beta into software and ad-exposed large caps within days, not months.